Srs Capital Advisors, Inc. Clene Inc. Transaction History

Srs Capital Advisors, Inc.

  • $901 Million
  • Q1 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Clene Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 55,250 shares of CLNN stock, worth $18,232. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,250
Previous 55,250 -0.0%
Holding current value
$18,232
Previous $16,000 43.75%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 22, 2022
BUY
$2.1 - $4.12 $6,300 - $12,360
3,000 Added 5.74%
55,250 $139,000
Q2 2021

Aug 02, 2021
BUY
$6.98 - $13.33 $364,705 - $696,492
52,250 New
52,250 $587,000

Others Institutions Holding CLNN

# of Institutions
54
Shares Held
7.44M
Call Options Held
48.1K
Put Options Held
160K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $21M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email